Anna V Tinker Selected Research

Anna V Tinker Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 01/2008
22	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 02/2009
19	Carcinoma (Carcinomatosis) 01/2023 - 02/2009
7	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 01/2008
6	Ovarian Epithelial Carcinoma 01/2023 - 01/2017
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2013
5	Disease Progression 11/2023 - 01/2017
3	Microsatellite Instability 01/2023 - 10/2021
3	Neutropenia 01/2021 - 12/2016
3	Fatigue 01/2021 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2017
2	Adenocarcinoma 01/2024 - 12/2018
2	Turcot syndrome 11/2023 - 01/2022
2	Hypoxia (Hypoxemia) 01/2023 - 01/2017
2	Fallopian Tube Neoplasms 12/2021 - 10/2012
2	Asthenia 01/2021 - 11/2017
2	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2016
2	Nausea 01/2018 - 11/2017
2	Anemia 11/2017 - 12/2016
1	Embolism (Embolus) 01/2024
1	Dyspnea (Shortness of Breath) 01/2024
1	Diarrhea 01/2024
1	Arthralgia (Joint Pain) 11/2023
1	Hypothyroidism 11/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Endometriosis 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2022
1	Phototoxic Dermatitis (Phototoxicity) 01/2022
1	Cicatrix (Scar) 01/2021
1	Exanthema (Rash) 01/2021
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Stomatitis 01/2021
1	Lymphatic Metastasis 02/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018
1	Vomiting 11/2017
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 11/2017
1	Rupture 11/2017
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 11/2017

Drug/Important Bio-Agent (IBA)

21	PlatinumIBA 01/2024 - 02/2009
13	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2012
8	rucaparibIBA 12/2021 - 01/2017
6	dostarlimabIBA 11/2023 - 11/2020
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 12/2016
4	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 02/2009
3	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2021
3	niraparibIBA 01/2019 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2009
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 01/2023
2	Alanine Transaminase (SGPT)IBA 11/2023 - 01/2021
2	pembrolizumabIBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 10/2021 - 11/2020
2	ParaffinIBA 01/2021 - 12/2014
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2008
2	Formaldehyde (Formol)FDA Link 01/2021 - 12/2014
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
1	neratinibIBA 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 11/2023
1	adavosertibIBA 07/2023
1	lenvatinibIBA 01/2023
1	Taxoids (Taxanes)IBA 01/2023
1	AnthracyclinesIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Carbonic Anhydrase IXIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	EnzymesIBA 01/2023
1	olaparibIBA 10/2022
1	ChromatinIBA 01/2022
1	CX 5461IBA 01/2022
1	Poly Adenosine Diphosphate RiboseIBA 12/2021
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	CreatinineIBA 01/2021
1	LigandsIBA 01/2021
1	NucleotidesIBA 01/2021
1	avelumabIBA 01/2021
1	monalizumabIBA 10/2019
1	Circulating Tumor DNAIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	IpilimumabIBA 12/2018
1	Bevacizumab (Avastin)FDA Link 10/2018
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Lys01IBA 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2016
1	Adenosine Diphosphate (ADP)IBA 12/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2016

Therapy/Procedure

20	Therapeutics 01/2024 - 01/2008
18	Drug Therapy (Chemotherapy) 01/2024 - 06/2014
3	Radiotherapy 01/2022 - 01/2013
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Aftercare (After-Treatment) 10/2021
1	Precision Medicine 10/2020
1	Lymph Node Excision (Lymph Node Dissection) 02/2020
1	Immunotherapy 12/2018
1	Adjuvant Radiotherapy 11/2017
1	Neoadjuvant Therapy 08/2015